ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 973

$714K Total Retail Price of All Prescriptions

Rank: 38 out of 973

625 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 625 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 625 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 15,012 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 768 665 1 3
LEVOTHYROXINE SODIUM 619 548 2 2
AMLODIPINE BESYLATE 596 548 3 7
HYDROCODONE-ACETAMINOPHEN 501 368 S3 4 4
FUROSEMIDE 466 428 5 6
POTASSIUM CHLORIDE 445 430 6 9
GABAPENTIN 434 344 7 12
METFORMIN HCL 373 337 8 8
OMEPRAZOLE 356 322 9 5
SIMVASTATIN 308 260 10 1
LOSARTAN POTASSIUM 297 271 11 19
WARFARIN SODIUM 289 284 12 10
METOPROLOL SUCCINATE 277 219 13 17
METOPROLOL TARTRATE 276 265 14 13
MELOXICAM 273 259 15 23
PRAVASTATIN SODIUM 272 245 16 22
HYDROCHLOROTHIAZIDE 271 245 17 11
CITALOPRAM HBR 249 217 18 14
ATENOLOL 242 229 19 16
CARVEDILOL 235 216 20 27
PAROXETINE HCL 197 194 21 66
ALLOPURINOL 185 167 22 29
CLOPIDOGREL 178 167 23 44
TRIAMTERENE-HCTZ 175 151 24 51
DIGOXIN 174 157 25 32
ZOLPIDEM TARTRATE 172 147 26 20
TRAMADOL HCL 162 137 27 18
ALENDRONATE SODIUM 155 141 28 24
ATORVASTATIN CALCIUM 151 109 29 15
FLUTICASONE PROPIONATE 141 125 30 35
POLYETHYLENE GLYCOL 3350 129 128 31 36
TAMSULOSIN HCL 129 112 31 28
SERTRALINE HCL 128 127 33 21
GEMFIBROZIL 125 106 34 83
ISOSORBIDE MONONITRATE ER 125 106 34 85
TRAZODONE HCL 124 103 36 48
RISPERIDONE 122 122 37 65
CYCLOBENZAPRINE HCL 119 64 R 38 42
NEXIUM 119 75 38 30
LANTUS 113 79 40 39
FAMOTIDINE 113 105 40 61
ADVAIR DISKUS 112 97 42 60
PLAVIX 111 96 43 78
CIPROFLOXACIN HCL 108 88 44 57
ROPINIROLE HCL 108 89 44 72
PREDNISONE 107 85 46 33
DONEPEZIL HCL 106 106 47 26
AZITHROMYCIN 98 84 48 47
CARBIDOPA-LEVODOPA 98 98 48 71
GLYBURIDE 94 68 R 50 59
BENAZEPRIL HCL 88 69 51 62
FENTANYL 87 59 S2 52 53
DIOVAN 87 86 52 63
PANTOPRAZOLE SODIUM 84 81 54 37
GLIPIZIDE 76 64 55 69
FLUOXETINE HCL 72 37 56 56
ENALAPRIL MALEATE 70 58 57 55
RAMIPRIL 69 58 58 114
FINASTERIDE 68 68 59 90
PRAMIPEXOLE DIHYDROCHLORIDE 67 44 60 152
MEGESTROL ACETATE 66 66 R 61 188
AMITRIPTYLINE HCL 65 44 R 62 52
DETROL LA 64 64 63 136
ONGLYZA 63 40 64 250
PHENYTOIN SODIUM EXTENDED 60 33 65 141
DIVALPROEX SODIUM 58 52 66 86
NYSTATIN-TRIAMCINOLONE 58 56 66 206
DILTIAZEM 24HR CD 57 57 68 104
GLIPIZIDE ER 56 52 69 135
CLONIDINE HCL 56 30 69 67
PREMARIN 55 44 R 71 116
PROPRANOLOL HCL 55 49 71 97
CEPHALEXIN 55 51 71 75
NITROFURANTOIN MONO-MACRO 54 54 74 185
DICLOFENAC SODIUM 53 29 75 108
LANTUS SOLOSTAR 53 33 75 99
CYMBALTA 53 44 75 40
METOCLOPRAMIDE HCL 52 49 78 93
NAMENDA 51 51 79 31
SYNTHROID 50 50 80 50
LOVASTATIN 50 48 80 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.